Literature DB >> 19963117

Detection of the t(11;14)(q13;q32) without CCND1/IGH fusion in a case of acute myeloid leukemia.

Marina Tarsitano1, Salvatore Palmieri, Felicetto Ferrara, Cira Riccardi, Maria Luigia Cavaliere, Laura Vicari.   

Abstract

The t(11;14)(q13;q32) is a hallmark of mantle cell lymphoma. It has been found less frequently in other lymphoproliferative disorders, such as B-prolymphocytic leukemia, plasma cell leukemia, chronic lymphocytic leukemia, and multiple myeloma. Here, we describe a patient with acute myeloid leukemia (AML), categorized as M5b according to French-American-British classification, in which conventional cytogenetic analysis revealed a karyotype with t(11;14)(q13;q32). Fluorescence in situ hybridization analyses demonstrated no rearrangement of the immunoglobulin heavy-chain (IGH) (14q32) locus as well as of the cyclin D1 (CCND1) gene, suggesting that this is not the typical t(11;14) resulting from the CCND1/IGH fusion. The changes in the 11q13 region have been described in both myeloid and lymphoid neoplasm with different chromosomes serving as donors in translocation, but to the best of our knowledge, never with the chromosome 14.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19963117     DOI: 10.1016/j.cancergencyto.2009.08.013

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  2 in total

1.  Prediction of deleterious single nucleotide polymorphisms and their effect on the sequence and structure of the human CCND1 gene.

Authors:  Bharath Yoganarasimha; Vivek Chandramohan; Thirupathihalli P Krishna Murthy; Bhavya S Gangadharappa; Gowrishankar B Siddaiah; Makari Hanumanthappa
Journal:  J Taibah Univ Med Sci       Date:  2016-09-27

2.  Characterization of genetic rearrangements in esophageal squamous carcinoma cell lines by a combination of M-FISH and array-CGH: further confirmation of some split genomic regions in primary tumors.

Authors:  Jia-Jie Hao; Zhi-Zhou Shi; Zhi-Xin Zhao; Yu Zhang; Ting Gong; Chun-Xiang Li; Ting Zhan; Yan Cai; Jin-Tang Dong; Song-Bin Fu; Qi-Min Zhan; Ming-Rong Wang
Journal:  BMC Cancer       Date:  2012-08-24       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.